Pharmafile Logo

B2B sales

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

Inizio

- PMLiVE

Bluebird and Celgene BCMA CAR-T kicks off ASCO

Will be reporting updated phase I trial data for bb2121in multiple myeloma patients

Lars Rebien Sørensen becomes chairman of Novo Holdings

He will take up the new role 1 July

Novartis changes executive committee

Robert Welteverden is appointed head of Novartis Business Services

- PMLiVE

It’s all about patient outcomes… right?

Lessons from history: a design thinking perspective

Global mHealth market predicted to reach $58.8bn by 2020

And digital therapeutics could rival mainstream pharmaceutical products, according to a report

VIDEO: Discover the power of IF

IF you could rely on high-quality creative advertising and marketing services, delivered on-time, on-budget and hassle-free, would that make a difference to your performance? IGNIFI can help.

IGNIFI

Bayer symbol

Loxo, Bayer get quick FDA review for ‘precision’ cancer drug

Bayer and Loxo hopeful about novel biomarker-led cancer treatment

Improving NHS sustainability through service redesign partnerships and effective communications

With year-on-year increases in demand and the imperative to reduce its deficits, the NHS must look beyond merely doing more of the same if it is to become sustainable. Never...

- PMLiVE

Improving childhood cancer survival rates in developing countries

IntroductionOne of the remarkable success stories in cancer care has been the increase in the long-term survival of children with leukaemia and solid tumours from almost nil to 75-80% cure...

NHS collaborates with VisualDX

CCGs will now have access to diagnostic clinical decision support resource

- PMLiVE

Real-world data finds patients feel better on Entresto, says Novartis

Patients on Entresto reported an “early, statistically significant improvement in health status”

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links